PUBLISHER: Verified Market Research | PRODUCT CODE: 1737186
PUBLISHER: Verified Market Research | PRODUCT CODE: 1737186
Rapid Saliva Testing Devices Market size was valued at USD 1.9 Billion in 2024 and is projected to reach USD 4.7 Billion by 2032, growing at a CAGR of 4.98% during the forecast period 2026-2032.
The growing application of saliva in various medical sectors, an increasing number of technological advancements in healthcare and medicines, adoption of drugs, medical procedures, and experiments will likely enhance the growth of the saliva test devices market in the forecast period. The Global Rapid Saliva Testing Devices Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.
Global Rapid Saliva Testing Devices Market Definition
Rapid saliva testing is a procedure that is carried out to collect a sample of saliva and check for the presence of drugs, antibodies, hormones, or other molecules. The device used to test the rapid saliva is called rapid saliva testing. It is a non-invasive monitoring tool that uses the sample of saliva for clinical diagnosis and therapeutic applications since saliva is an attractive diagnostic fluid and accurately diagnoses the state in humans.
Global Rapid Saliva Testing Devices Market Overview
The saliva test devices market also provides you with a detailed market analysis for every country's growth in healthcare expenditure for capital equipment, installed base of different kinds of products for the saliva test devices market, the impact of technology using lifeline curves and changes in healthcare regulatory scenarios, and their impact on the saliva test devices market. The increase in the number of applications of saliva in the medical sector is the major factor driving the growth of the global rapid saliva testing devices market.
Furthermore, advancements in technology in healthcare and medicines, the growing adoption of drugs, various medical procedures, and experiments are also expected to boost the growth of this market. In addition to this, changing lifestyles along with an increase in the rate of chronic diseases, and the user-friendly features that allow it to be used as a home care device are also likely to boost the growth of this market. However, inefficient storage procedures, high costs, and the dearth of skilled personnel are some of the factors that are restraining the growth of this market.
High costs associated with the usage of the device along with a lack of skilled personnel and expertise are acting as market restraints for the growth of the saliva test devices in the market.
Global Rapid Saliva Testing Devices Market Segment Analysis
Rapid Saliva Testing Devices Market is segmented into Type And Geography.
Based on Type, the market is bifurcated into 6-Panel Saliva Test Kits, 5-Panel Saliva Test Kits, 10-Panel Saliva Test Kits, 12-Panel Saliva Test Kits, and Others. 6-Panel Saliva Test Kits accounted for the largest market share of 31.01% in 2020, with a market value of USD 538.68 Million, and is projected to grow at a long-term CAGR of 6.65% during the forecast period. 5-Panel Saliva Test Kits was the second-largest market in 2020, valued at USD 464.71 Million in 2020.
The "Global Rapid Saliva Testing Devices Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are Abbott Laboratories, Quest Diagnostic, Guangzhou Wondfo Biotech, Neogen Corporation, Orasure Technologies, Oranoxis Inc, Premier Biotech, Securetec Detektions-Systeme, UCP Biosciences, etc.